Is INTS or JSPR more undervalued in 2026?

CirclFi compares Intensity Therapeutics, Inc. (INTS) and Jasper Therapeutics, Inc. (JSPR) using 13 institutional-grade valuation models. INTS has a Quality of Company score of 3.7/10 while JSPR scores 3.5/10.

Which is a better buy — INTS or JSPR?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do INTS and JSPR valuations compare?

INTS at $4.39 and JSPR at $0.83 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

INTS vs JSPR Valuation Comparison 2026 — Intrinsic Value Analysis

INTS

Biological Products, (No Diagnostic Substances)

Intensity Therapeutics, Inc.

Quality

3.7

out of 10

Value Trap

SAFE

Price

$4.39

Last close

Models

7/13

Active

JSPR

Biological Products, (No Diagnostic Substances)

Jasper Therapeutics, Inc.

Quality

3.5

out of 10

Value Trap

LOW

Price

$0.83

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	INTS Fair Value	INTS Upside	JSPR Fair Value	JSPR Upside
Bayesian DCF	Intrinsic	$3.31	-24.6%	$0.48	-42.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.26	-95.1%	$0.03	-96.7%
Dynamic NAV	Asset-Based	$8.03	+82.9%	$2.18	+163.1%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for INTS vs JSPR — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

INTS vs JSPR — Which Stock Is More Undervalued?

INTS scores higher with a 3.7/10 quality rating vs JSPR's 3.5/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Intensity Therapeutics, Inc. (INTS) and Jasper Therapeutics, Inc. (JSPR) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

INTS currently trades at $4.39 with a QOC of 3.7/10, while JSPR trades at $0.83 with a QOC of 3.5/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).